# LBO France

> LBO France is a VC fund in Paris backing Health Care and Software. See 38 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 38
- Last investment: Sep 2025
- Lead investor: 47%
- Fund size: $181M
- Last fund: Oct 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/lbo-france/
- Website: http://www.lbofrance.com/en

LBO France is a VC fund in Paris focused on Health Care and Software. LBO France is private equity firms in France.They offer exceptional coverage of the French market, with four interlocking areas of expertise: middle market buyouts (the White Knight funds), small cap buyouts (the Hexagone funds), real estate (the White Stone and Lapillus funds) and secondary debt (the Altercap funds). This breadth of specialistknowledge makes us a private equity leader in France – the second-largest economy in Europe and the fifth-largest in the world.With seasoned and diversified teams, a well-established position and in-depth knowledge of the French economy, LBO France offers management and investors of portfolio companies a wealth of experience and opportunities that spur value creation..Their strategy of diversification and growth has enabled us to achieve a critical mass that allows us to devote substantial financial and human resources to continuously improve the services they provide to their portfolio companies and investors.

## Contacts

5 contacts available for LBO France. Shizune tracks 11 team members at LBO France. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lbo-france?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2.9M–$18M |
| Series B | $16M–$200M |
| Venture - Series Unknown | $2.4M–$27M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 11 | 29% |
| Software | 8 | 21% |
| Medical | 7 | 18% |
| Medical Device | 5 | 13% |
| SaaS | 3 | 8% |

41 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 9 | 24% |
| Venture - Series Unknown | 8 | 21% |
| Series B | 5 | 13% |
| Series C | 3 | 8% |
| Private Equity | 3 | 8% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 19 | 50% |
| United Kingdom | 2 | 5% |
| Spain | 1 | 3% |
| Germany | 1 | 3% |
| Luxembourg | 1 | 3% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Franck Noiret | Managing Director - Venture Team | 5 | https://shizune.co/investors/profile/franck-noiret |
| Frederic Teboul | CFO Business Unit Venture | 0 | https://shizune.co/investors/profile/frdric-teboul |
| Jacques Franchi | Partner, Head of Debt and CIO | 0 | https://shizune.co/investors/profile/jacques-franchi |
| Jean-Marie Leroy | Partner | 0 | https://shizune.co/investors/profile/jean-marie-leroy |
| Marie-Astrid Auriol | Partner and CFO | 0 | https://shizune.co/investors/profile/marie-astrid-auriol |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Toothfairy | Tooth Fairy is a platform that connects patients to dentists through its patent-pending technology. | $10M | Series A | Sep 17, 2025 |  |
| Wandercraft | Wandercraft develops autonomous walking exoskeletons and robotic systems designed to restore upright mobility to individuals with walking impairments. The company offers devices such as Atalante X, a hands‑free, self‑balancing exoskeleton used in rehabilitation centers, and a Personal Exoskeleton prototype that leverages AI‑driven balance tosupport walking in daily life. Their systems incorporate real‑time adaptive gait algorithms and powered joints to facilitate multidirectional movement and support early intensive rehabilitation. Wandercraft collaborates with healthcare institutions and has initiated clinical trials to evaluate safety and effectiveness in managing spinal cord injuries and stroke rehabilitation. | $75M | Series D | Jun 06, 2025 |  |
| Siteflow | For many years digital transformation of the manufacturing industry has been underway. However, for regulated industries and operations that combine complex reporting workflows, project manufacturing and mobility for the field, few digital solutions meet the expectations. As a result, on those sites, tools and work methods haven’t changed so muchthe past decades while quality and safety requirements have exploded.That is around those challenges that professionnals from the nuclear industry, special works and software experts have gathered, to create Siteflow, the first cloud-based field service management software designed for complex operations (Nuclear, Oil&Gas…).A solution designed for end-userBeyond technical specificities from those markets, we have leveraged learnings from industries that have already been through digital transformation: every time user acceptance is key to make those challenging projects a success.This is why at Siteflow, our obsession is to design the most simple interfaces, and functionalities that bring value directly for our users, in order to simplify their daily tasks, to ease collaboration with their colleagues and to help them focus on what really matters.A change management program to facilitate digital transformationAs we all know, the choice of a software solution is just part of the puzzle to implement a digital transformation program. Organizations need to be re-designed as day-to-day activities of engineers, project managers and operators are directly concerned. Based upon our experience, we help our customers for a smooth transition to operational excellence. | $7.6M | Venture - Series Unknown | Mar 17, 2025 |  |
| Mediaire | mediaire GmbH is a software for computer-based diagnosis in radiology was developed, which is locally installed | $12.7M |  | Nov 13, 2024 |  |
| Impress | Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020. | $77M | Venture - Series Unknown | Nov 12, 2024 |  |
| Impress | Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020. | $40M | Debt Financing | Nov 12, 2024 |  |
| Diabeloop | Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes.The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France. | $16.3M | Venture - Series Unknown | Mar 04, 2024 |  |
| Stilla Technologies | Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System.Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all LifeSciences areas: research, therapeutics, and all the “omics”. | $26.5M | Series C | Feb 22, 2024 |  |
| Tribun Health | Tribun Health develops software solutions for digital pathology. | $16.5M | Series B | Sep 05, 2023 |  |
| Vestalis | Vestalis offers you a turnkey management service to manage your long-term furnished rental as simply as an empty rental. | $3.8M | Seed | Jun 27, 2023 |  |

10 of 38 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 8 deals together
- [Idinvest Partners](https://shizune.co/investors/profile/idinvest-partners) — VC Fund, 6 deals together
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 6 deals together
- [BNP Paribas Développement](https://shizune.co/investors/profile/bnp-paribas-developpement) — VC Fund, 4 deals together
- [Illumina Ventures](https://shizune.co/investors/profile/illumina-ventures) — VC Fund, 4 deals together
- [Cemag Invest](https://shizune.co/investors/profile/cemag-invest) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Brick & Mortar Ventures](https://shizune.co/investors/profile/brick-mortar-vc) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Foundamental](https://shizune.co/investors/profile/foundamental) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in France](https://shizune.co/investors/health-care-investors-france)
- [Health Care VC Funds in France](https://shizune.co/investors/health-care-vc-funds-france)
- [Medical Investors in France](https://shizune.co/investors/medical-investors-france)
- [Medical VC Funds in France](https://shizune.co/investors/medical-vc-funds-france)
- [Medical Device Investors in France](https://shizune.co/investors/medical-device-investors-france)
- [Construction Investors in France](https://shizune.co/investors/construction-investors-france)

## FAQ

### What does LBO France invest in?

LBO France invests primarily in Health Care, Software and Medical startups, most often at Series A and Venture - Series Unknown stage. Most of the 38 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is LBO France's check size?

LBO France typically joins rounds of $2.9M–$18M at Series A, $16M–$200M at Series B and $2.4M–$27M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LBO France participates in.

### How do I contact LBO France?

Public channels for LBO France include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at LBO France?

The team at LBO France includes Franck Noiret (Managing Director - Venture Team), Frederic Teboul (CFO Business Unit Venture) and Jacques Franchi (Partner, Head of Debt and CIO), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co